Q-Submissions
The FDA’s Q-Submission (Pre-Sub) process allows early dialogue to de-risk your submission and receive feedback on testing plans, classification, or data strategy.
We support clients by:
- Crafting precise questions and briefing documents
- Leading agenda-setting and FDA communication
- Mitigating regulatory risk early in the submission process
- Using our strong FDA relationships to guide productive outcomes
We help you use the Q-Sub process to your advantage—whether you’re preparing a 510(k), De Novo or PMA.
Trusted by top-tier teams worldwide
Featured case studies
Sorry, we couldn't find any posts. Please try a different search.